KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Factors associated with soil-transmitted helminths infection in Benin: Findings from the DeWorm3 study.PLoS Negl Trop DisPMID 34403424PMC83967662021-Aug0.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of the recombinant human growth hormone in short children born small for gestational age: A randomized, multicentre, comparative phase III trial.Medicine (Baltimore)PMID 34397702PMC83224932021-Jul-300.98未发现恶性肿瘤人群证据。待处理
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.N Engl J MedPMID 34320285无 PMCID2021-Jul-290.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.LancetPMID 34111416无 PMCID2021-Jul-240.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials.J Headache PainPMID 34301173PMC82996902021-Jul-230.98未发现恶性肿瘤人群证据。待处理
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.CellPMID 34161776PMC81791132021-Jul-220.98未发现恶性肿瘤人群证据。待处理
Trial of Pimavanserin in Dementia-Related Psychosis.N Engl J MedPMID 34289275无 PMCID2021-Jul-220.98未发现恶性肿瘤人群证据。待处理
Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial.Chin Med J (Engl)PMID 34310400PMC83823832021-Jul-220.98未发现恶性肿瘤人群证据。待处理
Exposure-safety analyses of nintedanib in patients with chronic fibrosing interstitial lung disease.BMC Pulm MedPMID 34289823PMC82935602021-Jul-210.98未发现恶性肿瘤人群证据。待处理
Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study.J Clin OncolPMID 33513313无 PMCID2021-Jul-200.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50.J Clin OncolPMID 33872070PMC82800892021-Jul-200.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Ten-year Outcomes After Drug-Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow-Up Study.J Am Heart AssocPMID 34238026PMC84834652021-Jul-200.98未发现恶性肿瘤人群证据。待处理
Activation of Glucagon-Like Peptide-1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism-Independent Pathway.J Am Heart AssocPMID 34250817PMC84835002021-Jul-200.98未发现恶性肿瘤人群证据。待处理
Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.JAMAPMID 34283183PMC82930252021-Jul-200.98未发现恶性肿瘤人群证据。待处理
Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM Studies.J Clin PsychiatryPMID 34288609无 PMCID2021-Jul-200.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.LancetPMID 34246358PMC82663012021-Jul-170.98未发现恶性肿瘤人群证据。待处理
Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial.J NeurotraumaPMID 33319651PMC82608942021-Jul-150.98未发现恶性肿瘤人群证据。待处理
Patient-Reported Outcomes From a Phase 3 Randomized Controlled Trial Exploring Optimal Sequencing of Short-Term Androgen Deprivation Therapy With Prostate Radiation Therapy in Localized Prostate Cancer.Int J Radiat Oncol Biol PhysPMID 33524545无 PMCID2021-Jul-150.95The study is a randomized Phase III oncology trial with a time-to-event endpoint (freedom from definitive deterioration), but the intervention is a sequencing strategy of radiation and androgen deprivation therapy, not a drug-containing regimen. The report focuses on patient-reported quality-of-life outcomes, which are secondary or exploratory endpoints in this context, not the primary/key secondary time-to-event efficacy endpoints (OS, PFS, DFS, etc.) for efficacy assessment.待处理
Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma.Int J Radiat Oncol Biol PhysPMID 33548338无 PMCID2021-Jul-150.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial.Clin Cancer ResPMID 33632930PMC82827402021-Jul-150.95This is a primary result report from a Phase III randomized trial in advanced soft-tissue sarcoma with a drug intervention (doxorubicin). However, it is excluded because the primary and key secondary endpoints are cardiotoxicity outcomes (e.g., LVEF deterioration, cardiac AEs), not a time-to-event efficacy endpoint (OS, PFS, DFS, etc.) required for the Kaplan-Meier digitization cohort.待处理
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.N Engl J MedPMID 34260836无 PMCID2021-Jul-150.98未发现恶性肿瘤人群证据。待处理
Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis.Arthritis Res TherPMID 34261541PMC82786832021-Jul-140.98未发现恶性肿瘤人群证据。待处理
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study.PLoS MedPMID 34260595PMC82793022021-Jul0.98未发现恶性肿瘤人群证据。待处理
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial.Respir MedPMID 34171789无 PMCID20210.98未发现恶性肿瘤人群证据。待处理
Differences in Pneumococcal and Haemophilus influenzae Natural Antibody Development in Papua New Guinean Children in the First Year of Life.Front ImmunolPMID 34447389PMC838310920210.98未发现恶性肿瘤人群证据。待处理
Genomic Profiling of Premenopausal HR+ and HER2- Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and Ribociclib.JCO Precis OncolPMID 34504990PMC842339720210.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial.Clin Exp RheumatolPMID 34622764无 PMCID20210.98未发现恶性肿瘤人群证据。待处理
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.Front ImmunolPMID 34659237PMC851164420210.98未发现恶性肿瘤人群证据。待处理
Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migraine.Front ImmunolPMID 34759933PMC857326220210.98未发现恶性肿瘤人群证据。待处理
Low-Dose-Rate versus High-Dose-Rate intracavitary brachytherapy in cervical cancer - Final Results of a Phase III randomized trial.BrachytherapyPMID 34598883无 PMCID20210.90The record describes a Phase III randomized trial in cervical cancer (oncology, human) with primary time-to-event efficacy endpoints (DFS, OS). However, the intervention is intracavitary brachytherapy (a radiotherapy technique), not a drug-containing intervention. Therefore, it does not meet the drug intervention criterion.待处理
Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.PLoS OnePMID 34748565PMC857529320210.98未发现恶性肿瘤人群证据。待处理
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.Front ImmunolPMID 34858404PMC863078620210.98未发现恶性肿瘤人群证据。待处理
Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line therapy for extensive-stage small-cell lung cancer.PLoS OnePMID 34780478PMC859244120210.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Comparison of biosimilar Tigerase and Pulmozyme in long-term symptomatic therapy of patients with cystic fibrosis and severe pulmonary impairment (subgroup analysis of a Phase III randomized open-label clinical trial (NCT04468100)).PLoS OnePMID 34941914PMC869963720210.98未发现恶性肿瘤人群证据。待处理
Autologous Infusion of Bone Marrow and Mesenchymal Stromal Cells in Patients with Chronic Obstructive Pulmonary Disease: Phase I Randomized Clinical Trial.Int J Chron Obstruct Pulmon DisPMID 35002228PMC873322020210.98未发现恶性肿瘤人群证据。待处理
Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B.PLoS OnePMID 34972191PMC871966120210.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Safety and efficacy of ashwagen (a standardized withania somnifera extract) in stress and anxiety with hypertension and associated cardiometabolic risk factors: a randomized, placebo-controlled trial.StressPMID 42105298无 PMCID2026-Dec-310.98未发现恶性肿瘤人群证据。待处理
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial.LancetPMID 41275875无 PMCID2026-Dec-200.98未发现恶性肿瘤人群证据。待处理
Comparison of inhalational methoxyflurane, intranasal fentanyl, and intravenous morphine for treatment of prehospital acute pain in Norway (PreMeFen): a randomised, non-inferiority, three-arm, phase 3 trial.LancetPMID 41275876无 PMCID2026-Dec-200.98未发现恶性肿瘤人群证据。待处理
Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial.LancetPMID 41275879无 PMCID2026-Dec-200.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Ivarmacitinib in patients with moderate to severe atopic dermatitis stratified by baseline characteristics: a post-hoc analysis of a phase 3 clinical trial.J Dermatolog TreatPMID 41612798无 PMCID2026-Dec0.98未发现恶性肿瘤人群证据。待处理
Safety and immunogenicity of diphtheria, tetanus and pertussis (acellular, three components) combined vaccine, adsorbed after three-dose priming in 2 months age infants: a randomized, blinded, controlled phase III clinical trial in China.Emerg Microbes InfectPMID 41615771PMC129122302026-Dec0.98未发现恶性肿瘤人群证据。待处理
Randomized, placebo-controlled phase 3 trial evaluating safety, immunogenicity, and reactogenicity of RSVPreF3-Mat in high-risk pregnant women and their infants.Hum Vaccin ImmunotherPMID 41766205PMC129591982026-Dec0.98未发现恶性肿瘤人群证据。待处理
Bimekizumab efficacy in scalp, nail and palmoplantar psoriasis versus comparators and over 4 years.J Dermatolog TreatPMID 41800601无 PMCID2026-Dec0.98未发现恶性肿瘤人群证据。待处理
Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis.J Dermatolog TreatPMID 41814992无 PMCID2026-Dec0.98未发现恶性肿瘤人群证据。待处理
Coadministration of mRNA-1345 RSV vaccine with high-dose quadrivalent influenza vaccine in adults aged 65 and older: An observer-blinded, placebo-controlled, randomized, phase 3 trial.Hum Vaccin ImmunotherPMID 42048601PMC131280232026-Dec0.98未发现恶性肿瘤人群证据。待处理
Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.J Dermatolog TreatPMID 42165315无 PMCID2026-Dec0.98未发现恶性肿瘤人群证据。待处理
Safety and durability of influenza and SARS-CoV-2 antibody responses through 6 months after a single dose of mRNA-1083, a multicomponent influenza and COVID-19 vaccine, in adults ≥50 years.Hum Vaccin ImmunotherPMID 42213900PMC132247552026-Dec0.98未发现恶性肿瘤人群证据。待处理
Immune correlates analysis in NextCOVE trial for a next-generation mRNA-1283 COVID-19 vaccine.Hum Vaccin ImmunotherPMID 42220116PMC132289342026-Dec0.98未发现恶性肿瘤人群证据。待处理
Safety and immunogenicity of 4CMenB and MenACWY-CRM meningococcal vaccines when administered concomitantly in healthy adolescents: A phase 3b, randomized, observer-blind study.Hum Vaccin Immunother疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 3 张 PMC Figure,均未识别为 KM 图:Figure 1.:非 KM 图;Figure 2.:AI 判定为 forest plot;Figure 3.:非 KM 图。PMID 42262312PMC132515182026-Dec0.98未发现恶性肿瘤人群证据。无 KM 图